Skip to content

Clinical trials

Terminated Phase 2 Neuralgia, Postherpetic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia, Postherpetic Phase: Phase 2 Status: Terminated Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20081
20092
20101
20111
20131
20141
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Allergan1
AstraZeneca1
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Novartis Pharmaceuticals1
Pfizer1
Ruhr University of Bochum1
University of California, San Francisco1
Winston Laboratories1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia, Postherpetic11
Pain5
Neuralgia4
Herpes Zoster3
Agnosia1
Causalgia1
Mononeuropathies1
Peripheral Nerve Injuries1
Polyneuropathies1
Radiculopathy1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.